|Bid||0.1650 x 0|
|Ask||0.1700 x 0|
|Day's Range||0.1600 - 0.1700|
|52 Week Range||0.1600 - 0.3450|
|Beta (3Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
CannTrust Holdings (TSX: TRST) (NYSE: CTST) has launched a cannabis education portal together with Well.ca. The resource is available to Ontario residents through Well.ca with additional provinces to launch soon. Well.ca will serve as a resource and education center for those interested in exploring medical cannabis, leveraging content, insights and expertise from CannTrust's medical business. […]The post Cannabis Stock News Daily Roundup May 28 appeared first on Market Exclusive.
VANCOUVER , May 24, 2019 /CNW/ - Cannara Biotech ("Cannara" or the "Company") (LOVE.CN) (8CB.F) (CNBTF), an emerging vertically integrated cannabis company focused on cultivation and cannabis-infused products, today announced the appointment of Dr. Sara May , PhD. Dr. May is recognized as an expert in the medical cannabis sector and will bring additional skill sets and help strengthen the Company's Board.
VANCOUVER , May 15, 2019 /CNW/ - Cannara Biotech ("Cannara" or the "Company") (LOVE.CN) (8CB.F) (CNBTF), an emerging vertically integrated cannabis company focused on the cultivation and sale of cannabis and cannabis-infused products to the Canadian and international markets, today announced its common shares are listed for trading on the OTCQB® Venture Market under the trading symbol "CNBTF". The OTC operates financial markets for approximately 10,000 U.S. and global securities. "Cannabis and hemp-CBD markets are global markets, with customers, vendors and investors domiciled across all major industrial nations," said Zohar Krivorot, President and CEO of Cannara.
SUNRISE, Fla., April 30, 2019 -- Profile Solutions, Inc. (OTC Pink: PSIQ) announced today that its wholly owned subsidiary, Elite Products International, Inc. (“Elite”), has.
MONTREAL , April 8, 2019 /CNW/ - Cannara Biotech ("Cannara" or the "Company") (CSE: LOVE FRA: 8CB), an emerging vertically integrated cannabis company focused on cultivation and cannabis-infused products, today announced the appointment of Jack Kay as a Director on Cannara's Board, effective immediately. Mr. Kay is generally recognized as one of Canada's leading pharmaceutical executives, having held senior positions in a number of firms, including CEO of Apotex. "A strong and independent board is not only vital for a successful public company, it can serve as a competitive advantage in the battlefield of commerce and growth," said Zohar Krivorot, President and CEO of Cannara Biotech.
Investorideas.com, a leading investor news resource covering hemp and cannabis stocks releases a snapshot focusing on the rise of CBD within the overall cannabis market in the US and internationally, and how companies are preparing to deal with this explosive market. With more CBD markets opening up, American Premium Water Corporation (OTC: HIPH), a diversified luxury consumer products company focused on businesses in the health and beauty and biotech sectors, recently announced that it has engaged A&R Opportunity to manage and fund a national sales team based out of Northeast Ohio that will help market and sell the Company’s products nationwide.
Cannara Biotech (OTCMKTS:CNBTF) subsidiary Global shopCBD.com has raised around $8.87 million in several rounds of private financing. The money will be used to expand the U.S. based online e-commerce platform, in which Cannara owns a majority stake, having a 61% ownership. Online Hemp-CBD Store for U.S. Customers Global shopCBD.com has entered the U.S. CBD-hemp market with […]The post Cannara Raises Over $8.8M to Grow Online Hemp-CBD Store appeared first on Market Exclusive.
SOL Global Investments (CSE: SOL) (OTCQB: SOLCF) (Frankfurt: 9SB) reported investment in premium soda-maker Jones Soda Co. (OTCQB: JSDA). SOL has acquired 3,396,049 common shares of Jones Soda in the open market. Neptune Wellness Solutions (NASDAQ: NEPT) (TSX: NEPT) has completed initial commercial production lots and is now shipping cannabis extracts from its licensed, GPP facility in Sherbrooke, Quebec. Cannara Biotech (OTCMKTS:CNBTF) […]The post Cannabis Stock News Daily Roundup March 26 appeared first on Market Exclusive.
With the recent passing of the 2018 Farm Bill in the U.S., CBD represents a developing sector with many vendors seeking national reach to U.S. customers. ShopCBD.com's strategy is to offer a wide variety of products from leading CBD brands, with competitive pricing and delivery times across the U.S. The rise in popularity for CBD products is driven by consumers seeking natural-based health & wellness solutions to treat various ailments from inflammation, anxiety to insomnia amongst many others.
MONTREAL , March 14, 2019 /CNW/ - Cannara Biotech Inc. ("Cannara" or the "Company") (LOVE.CN) (8CB.F), a vertically integrated cannabis company in the making focused on cultivation and cannabis-infused products, today announced an expansion of the Phase 1 build-out of Cannara's facility from 130,000 to 170,000 square feet. As a result, the license application at Cannara's Farnham , in process with Health Canada, has been modified accordingly. Separately, Besar Xhelili has resigned from the Company's Board of Directors to pursue other business interests.
With the global CBD movement supercharged by the 2018 U.S. Farm Bill, cannabis and beverage companies alike are officially beginning to launch CBD-infused beverage products in the U.S. market. In the order of being first-to-market based on what we know, here are four companies looking to shape the CBD-infused beverage industry. Recently, the Alkaline Water Company (WTER) (WTER.V), one of the fastest growing alkaline water companies in the U.S., announced that it had launched the first phase of its “A88 Infused Beverage Division” product line—with hemp infused alkaline water products to follow shortly.
MONTRÉAL, Feb. 11, 2019 /PRNewswire/ - Cannara Biotech Inc. ("Cannara Biotech" or the "Company") (LOVE.CN) (FRA:8CB), a vertically integrated cannabis company focused on cultivation and cannabis-infused products, today announced its common shares are listed for trading on the Frankfurt Stock Exchange under the trading symbol "8CB". The Frankfurt Stock Exchange is the tenth largest stock exchange in the world by market capitalization and third largest in terms of volume. "No doubt the world is becoming keenly interested in the global cannabis industry, and much of that enthusiasm and attention is turning towards Canadian companies who are at the forefront of innovating and leading this sector," said Zohar Krivorot, President and CEO of Cannara Biotech.
Montreal-based firm Cannara Biotech (OTCMKTS:CNBTF), which is focused on cannabis cultivation and cannabis-infused products, is planning to develop cannabinoid-infused beverages in partnership with a Quebec microbrewery. Cannara said it signed a letter of intent with an undisclosed Quebec microbrewery to develop cannabinoid-infused beverages. The company did not disclose more details about the agreement. "This agreement […]The post Cannara Biotech Plans to Develop Cannabinoid-Infused Beverages appeared first on Market Exclusive.
MONTRÉAL, Feb. 7, 2019 /CNW/ - Cannara Biotech Inc. ("Cannara Biotech" or the "Company") (LOVE.CN), a Montreal -based company that is building a vertically integrated cannabis company focused on cultivation and cannabis-infused products, today announced it has entered into a letter of intent with a leading Quebec microbrewery to develop cannabinoid-infused beverages. "Many of the world's most successful beverage companies have aggressively invested in Cannabinoid-infused product development underscoring this product category's market potential," said Zohar Krivorot, President and CEO of Cannara Biotech.
MONTRÉAL, Jan. 29, 2019 /CNW/ - Cannara Biotech Inc. ("Cannara" or the "Company") (LOVE.CN), is building a vertically integrated Cannabis company focused on cannabis derivative products, today announced its financial results for the three-month period ended November 30, 2018 . "On January 14th , Cannara became a publicly traded cannabis company, marking a critical milestone for our company," said Zohar Krivorot, President and CEO of Cannara. "As this release represents our first disclosure as a public company, we want to assure the investment community we understand that being public demands transparency, which is entirely consistent with our values of respect and integrity.